{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:00:27Z","timestamp":1760162427982,"version":"3.41.2"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["25A310007","24A310017"],"award-info":[{"award-number":["25A310007","24A310017"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["20HASTIT048"],"award-info":[{"award-number":["20HASTIT048"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102310368","252102311206"],"award-info":[{"award-number":["252102310368","252102311206"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","award":["2023ZDGGJS033"],"award-info":[{"award-number":["2023ZDGGJS033"]}],"id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bcp.2025.116997","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:57:41Z","timestamp":1748001461000},"page":"116997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TCPTP inhibition as a novel therapeutic strategy for esophageal squamous cell carcinoma: discovery and efficacy of COH29"],"prefix":"10.1016","volume":"239","author":[{"given":"Weiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-8203","authenticated-orcid":false,"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.bcp.2025.116997_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2025.116997_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082160","article-title":"The pathologic and molecular landscape of esophageal squamous cell carcinogenesis","volume":"12","author":"Businello","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.116997_b0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","article-title":"Global incidence of oesophageal cancer by histological subtype in 2012","volume":"64","author":"Arnold","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.116997_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/cgt.2017.16","article-title":"New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles","volume":"24","author":"Zaimy","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2025.116997_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","article-title":"Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.116997_b0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","article-title":"Update on management of squamous cell esophageal cancer","volume":"24","author":"Waters","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bcp.2025.116997_b0035","first-page":"1010","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors, Clin","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bcp.2025.116997_b0040","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1021\/acs.jmedchem.1c00969","article-title":"Discovery, optimization, and structure-activity relationship study of novel and potent RSK4 inhibitors as promising agents for the treatment of esophageal squamous cell carcinoma","volume":"64","author":"Yuan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm2203","article-title":"Mechanisms of specificity in protein phosphorylation","volume":"8","author":"Ubersax","year":"2007","journal-title":"Nat. Rev. Mol. Cell Bio"},{"key":"10.1016\/j.bcp.2025.116997_b0050","article-title":"T cell protein tyrosine phosphatase in osteoimmunology","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.116997_b0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.116997_b0060","article-title":"PTPN2 in the immunity and tumor immunotherapy: a concise review","volume":"23","author":"Song","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116997_b0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrm2039","article-title":"Protein tyrosine phosphatases: from genes, to function, to disease","volume":"7","author":"Tonks","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.116997_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805311","article-title":"PTPN2, A key predictor of prognosis for pancreatic adenocarcinoma, significantly regulates cell cycles, apoptosis, and metastasis","volume":"13","author":"Kuang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.116997_b0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140281","article-title":"Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development","volume":"131","author":"Katkeviciute","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.116997_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2019.11.047","article-title":"Upregulated PTPN2 induced by inflammatory response or oxidative stress stimulates the progression of thyroid cancer","volume":"522","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.116997_b0085","first-page":"4314","article-title":"Inflammatory response or oxidative stress induces upregulation of PTPN2 and thus promotes the progression of laryngocarcinoma","volume":"24","author":"Yang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.116997_b0090","doi-asserted-by":"crossref","first-page":"19044","DOI":"10.1002\/jcb.29227","article-title":"PTPN2 induced by inflammatory response and oxidative stress contributed to glioma progression","volume":"120","author":"Wu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2025.116997_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805311","article-title":"PTPN2, a key predictor of prognosis for pancreatic adenocarcinoma, significantly regulates cell cycles, apoptosis, and metastasis","volume":"13","author":"Kuang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.116997_b0100","doi-asserted-by":"crossref","first-page":"18343","DOI":"10.1074\/jbc.RA119.011060","article-title":"PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells","volume":"295","author":"Huang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107957","article-title":"PTPN2 deficiency enhances programmed T cell expansion and survival capacity of activated T cells","volume":"32","author":"Flosbach","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.116997_b0110","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2025.116997_b0115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2025.116997_b0120","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1089\/ars.2013.5720","article-title":"Protein tyrosine phosphatase inhibition by metals and metal complexes","volume":"20","author":"Lu","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.116997_b0125","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1021\/bi200438m","article-title":"Etoposide quinone is a redox-dependent topoisomerase II poison","volume":"50","author":"Jacob","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.116997_b0130","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/en.2008-0885","article-title":"Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys","volume":"150","author":"Swarbrick","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2025.116997_b0135","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1039\/c1dt11006c","article-title":"Potent inhibition of protein tyrosine phosphatases by quinquedentate binuclear copper complexes: synthesis, characterization and biological activities","volume":"40","author":"Wang","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bcp.2025.116997_b0140","first-page":"158","article-title":"Small Molecule Inhibitors of PTP1B and TCPTP","volume":"7","author":"Reddy","year":"2012","journal-title":"Res. J. Biotechnol."},{"key":"10.1016\/j.bcp.2025.116997_b0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41586-023-06575-7","article-title":"The PTPN2\/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity","volume":"622","author":"Baumgartner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.116997_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/2767-9764.CRC-21-0186","article-title":"Small-molecule PTPN2 inhibitors sensitize resistant melanoma to anti-PD-1 immunotherapy","volume":"3","author":"Zhu","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bcp.2025.116997_b0155","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41388-023-02750-2","article-title":"Diosmetin suppresses the progression of ESCC by CDK2\/Rb\/E2F2\/RRM2 pathway and synergies with cisplatin","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.116997_b0160","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/s41388-023-02762-y","article-title":"PGC-1\u03b1 promotes colorectal carcinoma metastasis through regulating ABCA1 transcription","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.116997_b0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171916","article-title":"Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets","volume":"9","author":"Zhao","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2025.116997_b0170","article-title":"Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116997_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112445","article-title":"DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90\u03b2","volume":"42","author":"Zhou","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.116997_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155235","article-title":"Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3","volume":"123","author":"Shi","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.116997_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02666-5","article-title":"Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth","volume":"42","author":"Jia","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.bcp.2025.116997_b0190","doi-asserted-by":"crossref","first-page":"17212","DOI":"10.1021\/acs.analchem.2c03863","article-title":"DNA aptamer selected against esophageal squamous cell carcinoma for tissue imaging and targeted therapy with integrin? 1 as a molecular","volume":"94","author":"Zhang","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129002","article-title":"Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy","volume":"259","author":"Qiao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2025.116997_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05883-0","article-title":"TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1\/eEF1A1 signal pathway","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116997_b0205","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1074\/jbc.M511546200","article-title":"Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding","volume":"281","author":"Montalibet","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0210","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/acs.biochem.1c00519","article-title":"Crystal structure of TCPTP unravels an allosteric regulatory role of helix \u03b17 in phosphatase activity","volume":"60","author":"Singh","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.116997_b0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb803","article-title":"Allosteric inhibition of protein tyrosine phosphatase 1B","volume":"11","author":"Wiesmann","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.116997_b0220","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","article-title":"High-resolution comparative modeling with RosettaCM","volume":"21","author":"Song","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2025.116997_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/prot.22540","article-title":"Structure prediction for CASP8 with all-atom refinement using Rosetta","volume":"77","author":"Raman","year":"2009","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"10.1016\/j.bcp.2025.116997_b0230","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bcp.2025.116997_b0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0240","article-title":"Design, synthesis, and structure-activity relationship study of potent MAPK11 inhibitors","volume":"27","author":"Gong","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.116997_b0245","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/cjoc.201900316","article-title":"Design and synthesis of a series of novel macrocycle Janus kinase 2 inhibitors","volume":"37","author":"Wang","year":"2019","journal-title":"Chin. J. Chem ."},{"key":"10.1016\/j.bcp.2025.116997_b0250","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1021\/acs.jmedchem.6b00505","article-title":"Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo f chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0255","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4155\/fmc.10.241","article-title":"Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development","volume":"2","author":"Barr","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.pharmtox.42.083001.144616","article-title":"Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development","volume":"42","author":"Zhang","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2025.116997_b0265","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4155\/fmc-2018-0089","article-title":"The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes","volume":"10","author":"Zhang","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0270","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/med.21871","article-title":"Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery","volume":"42","author":"Elhassan","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.116997_b0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.apsb.2020.07.010","article-title":"Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies","volume":"11","author":"Song","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.116997_b0280","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1002\/anie.201914525","article-title":"New promise and opportunities for allosteric kinase inhibitors","volume":"59","author":"Lu","year":"2020","journal-title":"Angew. Chem.-Int. Ed."},{"key":"10.1016\/j.bcp.2025.116997_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114022","article-title":"Discovery of novel TrkA allosteric inhibitors: Structure-based virtual screening, biological evaluation and preliminary SAR studies","volume":"228","author":"Guo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0290","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1021\/acs.jmedchem.2c01563","article-title":"Selective covalent targeting of pyruvate kinase M2 using arsenous warheads","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116997_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1585","article-title":"Along the allostery stream: Recent advances in computational methods for allosteric drug discovery","volume":"12","author":"Ni","year":"2022","journal-title":"Wiley Interdisc. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116997_b0300","unstructured":"Case D A, Betz R M, Cerutti D S, Cheatham III T E, T.A. Darden, Duke R E, Giese T J, Gohlke H, Goetz A W, Homeyer N, Izadi S, Janowski P, Kaus J, Kovalenko A, Lee T S, LeGrand S, Li P, Lin C, Luchko T, Luo R, Madej B, Mermelstein D, Merz K M, Monard G, Nguyen H, Nguyen H T, Omelyan I, Onufriev A, Roe D R, Roitberg A, Sagui C, Simmerling C L, Botello-Smith W M, Swails J, Walker R C, Wang J, Wolf R M, Wu X, Xiao L, K.P. A., AMBER 2016, University of California, San Francisco., in."},{"key":"10.1016\/j.bcp.2025.116997_b0305","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103637","article-title":"PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours","volume":"39","author":"Wiede","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.116997_b0310","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41590-019-0480-4","article-title":"PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity","volume":"20","author":"LaFleur","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.116997_b0315","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101914RR","article-title":"Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1","volume":"36","author":"Zhu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.116997_b0320","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","article-title":"A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)","volume":"25","author":"Mazzu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.116997_b0325","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1158\/0008-5472.CAN-13-1094","article-title":"A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance","volume":"73","author":"Zhou","year":"2013","journal-title":"Cancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T06:52:16Z","timestamp":1752648736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"alternative-id":["S0006295225002606"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116997","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TCPTP inhibition as a novel therapeutic strategy for esophageal squamous cell carcinoma: discovery and efficacy of COH29","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116997"}}